 BNET | A Glass Half Full: Avandia Case Reveals Hole in FDA's Conflict-of-Interest Rules BNET ... or that she has given talks sponsored by AstraZeneca (maker of Seroquel), and has been a consultant for Shire (maker of Adderall XR and Vyvanse). and more » |
FDA Sends Shire Letter Over Intuniv Promotional Material PharmaLive.com (press release) ROCKVILLE, Md., June 30, 2010 - The FDA today posted on its website a letter sent to Shire regarding a DTC Patient Starter Kit, which includes a Parents' ... and more » |
Shire Should Return to Growth in 2010 Morningstar Vyvanse launched as a pediatric treatment in the US in 2007, and sales have soared since approval in the adult indication in 2008. ... and more » |
 Hemscott | Shire Should Return to Growth in 2010 Hemscott Vyvanse launched as a pediatric treatment in the US in 2007, and sales have soared since approval in the adult indication in 2008. ... and more » |
Shire Presents Positive Data Daily Markets Recently, Shire Plc. (NASDAQ:SHPGY) presented data from a late stage trial of Vyvanse, which was conducted to study the safety and efficacy of the product ... and more » |